A Phase 2/3 interventional study of Ropivacaine in Anesthesia, Local, Anesthesia and Orthopedic Disorder, sponsored by Ochsner Health System. Completed at 1 site in United States. Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-07-29.
Sponsored by Ochsner Health System · Phase 2/3, Interventional, and Treatment
To identify the benefits from regional anesthesia use as pain management in the pediatric population by delineating the differences in efficacy of continuous nerve blockade versus single-shot techniques after pediatric orthopaedic limb procedures. By doing this, the investigators can determine if specific anesthetic techniques should become a standard of care in pain management for the pediatric population and supersede the need for opioid medication.
657 studies on the registry are indexed under Musculoskeletal Diseases; 159 are open to participants now.
This study's enrollment of 24 is below the median of 73 across 438 interventional studies indexed under Musculoskeletal Diseases.
Browse Musculoskeletal Diseases studies →Ochsner Health System is the lead sponsor of 54 studies on the registry; 7 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Various types of regional anesthesia blocks will be performed based on the patient's injuries including fascia iliaca plane blocks, femoral nerve blocks, adductor canal blocks, popliteal approach sciatic nerve blocks, and saphenous nerve blocks A catheter will be placed for the given block for 48 hours. Those patients undergoing lower limb orthopaedic surgery will be randomized into single shot or continuous (catheter) regional anesthesia.
Drug: Ropivacaine
Various types of regional anesthesia blocks will be performed based on the patient's injuries including fascia iliaca plane blocks, femoral nerve blocks, adductor canal blocks, popliteal approach sciatic nerve blocks, and saphenous nerve blocks. These blocks will be given via a single dose or "single shot". Those patients undergoing lower limb orthopaedic surgery will be randomized into single shot or continuous (catheter) regional anesthesia.
Drug: Ropivacaine
Various types of regional anesthesia blocks involving the brachial plexus will be performed based on the patient's injuries. A catheter will be placed for the given block for 48 hours. Those patients undergoing upper limb orthopaedic surgery will be randomized into single shot or continuous (catheter) regional anesthesia.
Drug: Ropivacaine
Various types of regional anesthesia blocks involving the brachial plexus will be performed based on the patient's injuries. A catheter will be placed for the given block for 48 hours. Those patients undergoing upper limb orthopaedic surgery will be randomized into single shot or continuous (catheter) regional anesthesia.
Drug: Ropivacaine
Dosing and volume will vary based on type of block used and weight of patient because of the pediatric population in the study.
Opioid Consumption
Amount of opioid medications taken for pain control.
Time frame: For first 48 hours post-operatively.
Opioid Consumption
Amount of opioid medications taken for pain control.
Time frame: Through 12 hours post-operatively.
Opioid Consumption
Amount of opioid medications taken for pain control.
Time frame: Through 24 hours post-operatively.
Opioid Consumption
Amount of opioid medications taken for pain control.
Time frame: Through 36 hours post-operatively.
Opioid Consumption
Amount of opioid medications taken for pain control.
Time frame: Through 48 hours week post-operatively.
Opioid Consumption
Amount of opioid medications taken for pain control.
Time frame: Through 72 hours post-operatively.
Opioid Consumption
Amount of opioid medications taken for pain control.
Time frame: Through 96 hours post-operatively.
Opioid Consumption
Amount of opioid medications taken for pain control.
Time frame: Through 120 hours post-operatively.
Opioid Consumption
Amount of opioid medications taken for pain control.
Time frame: Through 144 hours post-operatively.
Opioid Consumption
Amount of opioid medications taken for pain control.
Time frame: Through 168 hours post-operatively.
Emergency Room Visits
Emergency room visits due to poor pain control.
Time frame: Within 2 weeks post-operatively.
Pain Scores
Universal Pain Assessment tool will be used. The pain scale ranges from 0 to 10 with 0 being no pain and 10 being the worst possible pain.
Time frame: At 12 hours post-operatively.
Pain Scores
Universal Pain Assessment tool will be used. The pain scale ranges from 0 to 10 with 0 being no pain and 10 being the worst possible pain.
Time frame: At 24 hours post-operatively.
Pain Scores
Universal Pain Assessment tool will be used. The pain scale ranges from 0 to 10 with 0 being no pain and 10 being the worst possible pain.
Time frame: At 36 hours post-operatively.
Pain Scores
Universal Pain Assessment tool will be used. The pain scale ranges from 0 to 10 with 0 being no pain and 10 being the worst possible pain.
Time frame: At 48 hours post-operatively.
Pain Scores
Universal Pain Assessment tool will be used.The pain scale ranges from 0 to 10 with 0 being no pain and 10 being the worst possible pain.
Time frame: At 72 hours post-operatively.
Pain Scores
Universal Pain Assessment tool will be used.The pain scale ranges from 0 to 10 with 0 being no pain and 10 being the worst possible pain.
Time frame: At 96 hours post-operatively.
Pain Scores
Universal Pain Assessment tool will be used.The pain scale ranges from 0 to 10 with 0 being no pain and 10 being the worst possible pain.
Time frame: At 120 hours post-operatively.
Pain Scores
Universal Pain Assessment tool will be used.The pain scale ranges from 0 to 10 with 0 being no pain and 10 being the worst possible pain.
Time frame: At 144 hours post-operatively.
Pain Scores
Universal Pain Assessment tool will be used.The pain scale ranges from 0 to 10 with 0 being no pain and 10 being the worst possible pain.
Time frame: At 168 hours post-operatively.
Pain Scores
Universal Pain Assessment tool will be used. The pain scale ranges from 0 to 10 with 0 being no pain and 10 being the worst possible pain.
Time frame: At 2 weeks post-operatively.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Ochsner Health System